Pfizer COVID-19 vaccine 90% effective at preventing hospitalization, even with delta variant: Study
WBAL Radio 1090 AM - Pfizer COVID-19 vaccine 90% effective at preventing hospitalization, even with delta variant: Study
Stay updated with breaking news from Simone Wildes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WBAL Radio 1090 AM - Pfizer COVID-19 vaccine 90% effective at preventing hospitalization, even with delta variant: Study
WBAL Radio 1090 AM - Pfizer COVID-19 vaccine 90% effective at preventing hospitalization, even with delta variant: Study
WBAL Radio 1090 AM - Pfizer COVID-19 vaccine 90% effective at preventing hospitalization, even with delta variant: Study
The Pfizer COVID-19 vaccine remains 90% effective at reducing a person's risk of hospitalization from the virus six months after it is administered, a new study has found. This is true even in the face of the delta variant as well as if the person has not received a booster shot.
No_limit_pictures/iStock(NEW YORK) -- The Pfizer COVID-19 vaccine remains 90% effective at reducing a person's risk of hospitalization from the virus six months after it is administered, a new study has found. This is true even in the face of the delta variant as well as if the person has not received a booster shot. Still, when it comes to preventing infections, the vaccine's effectiveness wanes rapidly as time passes, the study found. After five months, it is just 47% effective at preventing infection. In the study, funded by Pfizer, researchers assessed data from Kaiser Permanente...